| Supplement Facts | ||
| Serving Size: 1 Tablet | ||
| Amount | % Daily | |
| Per Serving | Value | |
| Vitamin C (as Ascorbic Acid) | 500 mg | 556% |
| Vitamin E (as dl-Alpha Tocopheryl Acetate) | 13.5 mg | 90% |
| Folate (as L-5-methyltetrahydrofolate Calcium) | 1,020 mcg DFE | 255% |
| (600 mcg L-5-MTHF) | ||
| Vitamin B12 (as Cyanocobalamin) | 60 mcg | 2,500% |
| Biotin | 150 mcg | 500% |
| Iron (as Carbonyl Iron) | 150 mg | 833% |
| Copper (as Cupric Sulfate) | 3 mg | 333% |
| *Daily Value not established. |
OTHER INGREDIENTS:
Microcrystalline Cellulose, Citric Acid, Stearic Acid, Dicalcium Phosphate, Croscarmellose Sodium, Polyvinylpyrrolidone, Hypromellose, Magnesium Stearate, Silicon Dioxide, Starch, Glucose, Calcium Carbonate, Crospovidone, Isomalt, Sodium Lauryl Sulfate, Maltodextrin, Triglycerides, Sucrose, Soy Polysaccharide, Glycerin, Mineral Oil, Polyethylene Glycol, Artificial French Vanilla Flavor, Annatto Extract (color), Propylene Glycol, Tricalcium Phosphate, Potassium Hydroxide, and Talc. Contains: Soy
Contains a bioengineered food ingredient.
HEMATRON AF is a multi-vitamin / multi-mineral dietary supplement indicated for use in improving the nutritional status of patients with iron deficiency†
| †This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. |
| WARNING Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6 years of age. KEEP THIS PRODUCT OUT OF REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately. |
DO NOT USE with individuals with a known hypersensitivity to any of the ingredients. Patients with hemochromatosis and hemosiderosis are contra-indications to iron therapy. This product is not for use in children under 12 years of age.
CAUTION:
This product contains 1,020mcg DFE (600mcg L5-MTHF); the maximum safe Reference Daily Intake (RDI) amount for this nutrient is 1000mcg. Folic Acid in doses above 0.1 mg (1000mcg) daily may obscure pernicious anemia in that hematologic remission can occur while neurologic manifestations remain progressive. There is a potential danger in administering folic acid to patients with undiagnosed anemia since folic acid may obscure the diagnosis of pernicious anemia by alleviating the hematologic manifestations of the disease while allowing the neurologic complications to progress. This may result in severe nervous system damage before the correct diagnosis is made. Adequate doses of vitamin B12 may prevent, halt, or improve the neurologic changes caused by pernicious anemia.
ADVERSE REACTIONS
Allergic sensitization has been reported following both oral and parenteral administration of Folic Acid.
DIRECTIONS FOR USE
One caplet daily with or without food or as prescribed by your healthcare provider.
